BioSpace News Archive

Relay Therapeutics’ leadership in this new breed of biotech positions the company as a strategic partner of choice for emerging technologies and founders in these fields

Defying predictions, physician salaries held steady in 2020, a combination of pivoting to telehealth, leveraging government programs and reducing staff to minimize the impact of office closures and restrictions on elective procedures during the Covid-19 pandemic, according to the findings of the 2021 Medscape Physician Compensation Report: The Recovery Begins.

CareDx, Inc., a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced it will be exhibiting at the 29th Annual UNOS Transplant Management Forum, which takes place virtually between April 19-22, 2021.

PetVivo Holdings, Inc. (OTCQB: PETV) (the “Company”) an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets is pleased to announce that Robert J. Folkes has accepted a position with the Company as its new Chief Financial Officer.

Prescience Point Capital Management, together with its affiliates (“Prescience Point”), a research-focused, catalyst-driven investment firm, announced today the nomination of four highly qualified director candidates to the Board of Directors (the “Board”) of MiMedx Group, Inc.

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced that it will release its first quarter 2021 financial results after the market closes on Thursday May 6, 2021

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has exercised its right of first refusal to expand the lease for its “Factory of the Future” manufacturing facility near Portland, Oregon.

Modernizing Medicine today announced that its wholly-owned subsidiary, Modernizing Medicine Podiatry Systems, has acquired TRAKnet and other assets from podiatric electronic health records (EHR) vendor NEMO Health.

Immersion Corporation (NASDAQ: IMMR), the leading developer and provider of technologies for haptics, today announced that it will report financial results for the first quarter of 2021 on Thursday, May 6, 2021, after market close.

Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), today announced that the Tiara Transapical system (“Tiara TA”) will be unable to receive a European CE mark under the current Medical Device Directive regulations (“MDD”) ending on May 26, 2021.